Fetal factors |
Suspected cardiac abnormality on screening ultrasound |
Increased nuchal translucency thickness |
Fetal hydrops |
Fetal abnormality with known association of congenital heart disease |
e.g., exomphalos, diaphragmatic hernia |
Fetal arrhythmia |
Abnormal fetal karyotype, e.g., trisomy 21 |
Maternal and familial risk factors |
Family history of congenital heart disease (CHD) in a first degree relative. |
Diabetes mellitus – Mothers who are established diabetics on treatment |
Mothers with a tendency toward diabetes that is solely related to pregnancy are not judged candidates for fetal echocardiography |
Mothers taking known teratogenic drugs, e.g., anticonvulsants, lithium |
Maternal anti - Ro or anti - La antibodies |
Mothers who have anti-Ro and / or La antibodies are candidates for fetal cardiology assessment, in view of the risk of developing fetal heart block. Mothers NOT having anti Ro or La antibodies are not candidates for fetal echocardiography |
Maternal infections, e.g., parvovirus, Coxsackie |